Colangelo Admits Mistake When Classifying Joel Embiid's Injury

CAMDEN, N.J. -- In retrospect, the Sixers would have done things differently.

For more than a month, the team did not announce a timeframe for Joel Embiid's return from a left knee contusion. After he missed 14 of the last 15 games, the Sixers said on Wednesday Embiid would be out the next four games and are targeting a March 3 return.

The next day, president of basketball operations Bryan Colangelo addressed the lack of timetable provided. 

"We should have just said 'out indefinitely,' even though the treatment was still day to day," Colangelo said. "But the fact that there was uncertainty, I'll own that."

Embiid's injury goes back to Jan. 22 when he suffered the contusion against the Trail Blazers. After the Sixers held him out three games, he played on Jan. 27 against the Rockets and has been sidelined since.

Embiid was very candid on Thursday in expressing his displeasure of how his injury news had been shared. While he had been optimistic he would return earlier than March, citing a recovery period of less than a month, it didn't line up with the day-to-day status.

Philadelphia 76ers

Complete coverage of the Philadelphia 76ers and their rivals in the NBA from NBC Sports Philadelphia.

Sixers vs. Knicks playoff schedule released with No. 2 vs. No. 7 matchup locked in

3 observations after Sixers storm back, earn thrilling play-in win over Heat 

"I wasn't too happy with the way it was kind of handled before," Embiid said.

"I saw the day-to-day part. I was told that I was going to miss at least two or three weeks. So I wasn't happy with the way it was handled.

"I thought keeping my name out there was going to just like literally have people think about me all the time instead of just saying when I was going to be back. So I'm happy that they did that today and they said that I'm out for the next four games."

Colangelo addressed that timetable.

"The two-to-three week comment, I think I know where that came from," Colangelo said. "There was a lot of discussion, and despite the fact that we were saying it's day-to-day treatment and evaluation, two to three weeks may have been mentioned as a possibility of what it may be. But a possibility.

"To say that publicly may not have been the best thing at the time because I was also told sometimes it's four to six weeks for a bone bruise to resolve itself."

The lack of clarity on Embiid's return had upset Sixers fans who wanted more transparency. They had been through years of lengthy injuries, including the past two with Embiid, and were frustrated by this recent absence.

"There's never, ever been any effort to deceive fans, to mislead fans, to mislead [media]," Colangelo said. "We give the information as we're given the information. We've got very good medical care, very good medical oversight. Everything is explainable, but injuries are unpredictable is the best way I can describe it."

Embiid isn't the only player whose status was made public this week. On Friday, Colangelo also announced Ben Simmons will miss the remainder of this season. The first overall pick has been sidelined since training camp after suffering a Jones fracture in his right foot.

"There's no deceit, there's no movement toward doing anything to be dishonest here at all. It's quite simple," Colangelo said. "Injuries are a hard thing to manage. Injuries are a harder thing to manage with daily interface with the media, the public, games being played, the schedule, no practice, practice -- it's a sensitive issue. 

"And you're not talking about simple things. You're talking about complex injuries, you're talking about high-level performers and I'm calling them our stars. They're the ones everyone wants to see. Ben Simmons and Joel Embiid. And they're both out. Nobody is more frustrated than them."

After not committing to injury timetables, the Sixers are committing to taking a different approach. 

"It was our mistake to put out 'day-to-day' opposed to 'out indefinitely,' Colangelo said. "But that mistake will not be made again."

Copyright CSNPhily
Contact Us